tiprankstipranks
Advertisement
Advertisement

CHRS Stock Latest News

Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
RatingsCoherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
13d ago
CHRS
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
PremiumRatings
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
15d ago
CHRS
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
PremiumThe Fly
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
16d ago
CHRS
Options Volatility and Implied Earnings Moves Today, March 09, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 09, 2026
16d ago
DDD
HPE
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
CHRS
Coherus Biosciences Completes $47 Million Equity Offering
PremiumCompany AnnouncementsCoherus Biosciences Completes $47 Million Equity Offering
1M ago
8K
CHRS
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
Premium
The Fly
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
1M ago
CHRS
Coherus Oncology announces common stock offering, no amount given
Premium
The Fly
Coherus Oncology announces common stock offering, no amount given
1M ago
CHRS
Coherus Signs Clinical Supply Deal With Janssen Oncology
PremiumCompany Announcements
Coherus Signs Clinical Supply Deal With Janssen Oncology
2M ago
8K
CHRS
Coherus Biosciences Updates ATM Equity Offering Program
PremiumCompany Announcements
Coherus Biosciences Updates ATM Equity Offering Program
2M ago
8K
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
PremiumThe Fly
Coherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
2M ago
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer
PremiumThe Fly
Coherus Oncology initiated with an Outperform at Oppenheimer
2M ago
CHRS
Coherus Oncology announces publication highlighting CCR8 antibody tagmokitug
PremiumThe FlyCoherus Oncology announces publication highlighting CCR8 antibody tagmokitug
3M ago
CHRS
Coherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
Premium
Ratings
Coherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
4M ago
CHRS
Coherus Oncology announces six-year OS results from Phase 3 JUPITER-02 trial
Premium
The Fly
Coherus Oncology announces six-year OS results from Phase 3 JUPITER-02 trial
4M ago
CHRS
Coherus Biosciences Divests UDENYCA Business
PremiumCompany Announcements
Coherus Biosciences Divests UDENYCA Business
4M ago
8K
CHRS
Coherus Oncology files $150M mixed securities shelf
PremiumThe Fly
Coherus Oncology files $150M mixed securities shelf
4M ago
CHRS
Coherus Biosciences Earnings Call Highlights Strong Growth and Strategic Focus
PremiumCompany Announcements
Coherus Biosciences Earnings Call Highlights Strong Growth and Strategic Focus
5M ago
CHRS
Optimistic Buy Rating for Coherus Biosciences Driven by Promising Oncology Pipeline and Strategic Focus
PremiumRatings
Optimistic Buy Rating for Coherus Biosciences Driven by Promising Oncology Pipeline and Strategic Focus
5M ago
CHRS
Coherus Biosciences: Strategic Growth Potential and Strong Market Ambitions Justify Buy Rating
PremiumRatingsCoherus Biosciences: Strategic Growth Potential and Strong Market Ambitions Justify Buy Rating
5M ago
CHRS
Coherus Biosciences announces data from Phase 1b trial of CHS-114
Premium
The Fly
Coherus Biosciences announces data from Phase 1b trial of CHS-114
5M ago
CHRS
Coherus Oncology Reports Q3 2025 Financial Results
Premium
Company Announcements
Coherus Oncology Reports Q3 2025 Financial Results
5M ago
CHRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >